CJC 1295 No DAC (5mg) + Ipamorelin (10mg) Pre Mixed Pen Peptide Blend

Description

What is CJC 1295 No DAC + Ipamorelin (5mg + 10mg)?

CJC 1295 No DAC + Ipamorelin is an advanced peptide blend specifically designed to stimulate natural growth hormone (GH) production, supporting benefits like improved muscle growth, fat loss, enhanced recovery, and overall physical health. This blend combines the powerful effects of CJC 1295 No DAC and Ipamorelin, which work synergistically to optimize growth hormone secretion. However, it’s important to note that this peptide blend has not been evaluated by the U.S. Food and Drug Administration (FDA) for medical or therapeutic use and is strictly intended for research purposes.

• CJC 1295 No DAC is an analog of Growth Hormone Releasing Hormone (GHRH). By stimulating the pituitary gland to release more growth hormone, CJC 1295 No DAC provides a controlled and precise release of GH, allowing for a more tailored approach. The absence of DAC allows for a shorter half-life, which enables better control over GH levels.

• Ipamorelin is a highly selective growth hormone secretagogue that activates ghrelin receptors to naturally induce GH release without stimulating appetite. When paired with CJC 1295 No DAC, Ipamorelin’s effectiveness is enhanced, making it an ideal combination for those looking to optimize performance and health.

Key Benefits:

• Increased Muscle Mass & Strength: Boosts GH levels, leading to enhanced muscle development and strength.

• Fat Loss & Improved Body Composition: Accelerates metabolism and fat burning, improving body composition.

• Faster Recovery: Enhances tissue repair and recovery after strenuous workouts or injuries.

• Improved Sleep Quality: Promotes deeper, more restorative sleep, essential for health and performance.

• Anti-Aging Properties: Supports skin health, reduces wrinkles, and strengthens bones, potentially slowing aging effects.

Dosage & Usage

• Recommended Dosage: 10–14 units per day (split between AM and PM).

• Administration: Subcutaneous injection into the abdomen or thigh. Rotate sites to avoid irritation.

• Injection Instructions:

  • Set dial to 5–7 units per dose.

  • Each unit delivers 25mcg CJC 1295 + 50mcg Ipamorelin.

  • Wait 10 seconds post-injection before needle removal.

• Cycle Duration: 4–6 months for sustained research cycles.

• Pen Size: Each pen contains 200 units, offering approximately 20 days of research use.

Dosage Breakdown (Per 200-Unit Pen)

• 1 unit = 25mcg CJC 1295 + 50mcg Ipamorelin

• 5 units = 125mcg CJC 1295 + 250mcg Ipamorelin

• 10 units = 250mcg CJC 1295 + 500mcg Ipamorelin

• 14 units = 350mcg CJC 1295 + 700mcg Ipamorelin

Possible Side Effects

Side effects observed in preclinical settings include:

• Injection site redness or irritation

• Mild headache

• Temporary water retention

• Rare instances of increased appetite

These effects are usually mild and self-limiting in nature.

Storage & Handling

• Storage Conditions: Store refrigerated at 2°C to 8°C (36°F to 46°F).

• Packaging: Shipped in temperature-controlled packaging to preserve product integrity.

Why Choose Pen Peptide?

• High Purity: This peptide blend is synthesized with over 99% purity for maximum effectiveness.

• Reliable Sourcing: Sourced from certified laboratories to ensure top-quality peptides.

• Fast Delivery: Shipped in temperature-controlled packaging to maintain product integrity during transportation.

 

Disclaimer:

This product has not been evaluated by the U.S. Food and Drug Administration (FDA). It is not intended to diagnose, treat, cure, or prevent any disease. CJC 1295 No DAC + Ipamorelin is for research purposes only and should be handled exclusively by trained professionals in a controlled research setting.